Thirumalai Chemicals (TIRUMALCHM)₹121.37+2.12%Commodity Chemicals
In the Jun 2026 quarter (consolidated), Thirumalai Chemicals reported sales of ₹547 Cr, up 21.5% from Jun 2025, and net profit of −₹44.12 Cr. For the year to Mar 2026, sales were ₹1,737 Cr and net profit −₹168 Cr.
Company filings, consolidated accounts; latest reported quarter Jun 2026
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 542 | 492 | 527 | 555 | 526 | 447 | 524 | 450 | 445 | 416 | 424 | 547 |
| Expenses | 529 | 499 | 525 | 525 | 504 | 468 | 510 | 479 | 450 | 432 | 419 | 516 |
| Operating Profit | 14.96 | −5.98 | 3.99 | 30.91 | 23.93 | −19.93 | 14.95 | −26.90 | −3.99 | −14.97 | 5.98 | 32.92 |
| OPM % | 2.9% | −1.2% | 0.7% | 6.0% | 4.5% | −4.5% | 2.8% | −6.0% | −0.8% | −3.6% | 1.4% | 6.0% |
| Other Income | 6.02 | 4.01 | 4.01 | 3.01 | 9.03 | 0.00 | 8.03 | 2.01 | 8.02 | 4.01 | 0.00 | 3.01 |
| Interest | 9.98 | 11.97 | 9.97 | 8.97 | 9.98 | 13.96 | 14.97 | 17.95 | 25.93 | 20.95 | 23.95 | 51.89 |
| Depreciation | 15.95 | 14.96 | 16.96 | 13.97 | 12.96 | 15.95 | 17.97 | 21.92 | 22.96 | 22.95 | 20.94 | 22.93 |
| Profit before tax | −4.01 | −29.01 | −19.01 | 11.02 | 9.01 | −50.04 | −11.01 | −64.05 | −44.01 | −55.01 | −38.03 | −39.06 |
| Tax % | 47.0% | −20.0% | 10.0% | 53.0% | 47.0% | −16.0% | 28.0% | −7.0% | −24.1% | −16.0% | −27.0% | 12.0% |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | −7.99 | 0.00 |
| Net Profit | −6.01 | −23.07 | −20.03 | 5.01 | 5.01 | −42.06 | −14.04 | −60.11 | −33.07 | −47.13 | −28.05 | −44.12 |
| EPS (Rs) | −0.58 | −2.25 | −1.99 | 0.51 | 0.49 | −4.09 | −1.36 | −5.85 | −2.82 | −3.85 | −2.33 | −3.61 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 941 | 1,029 | 1,313 | 1,261 | 1,086 | 1,087 | 2,001 | 2,134 | 2,085 | 2,053 | 1,737 | 1,833 |
| Expenses | 845 | 873 | 1,025 | 1,058 | 1,010 | 868 | 1,562 | 1,952 | 2,040 | 2,008 | 1,777 | 1,818 |
| Operating Profit | 97.63 | 157 | 289 | 205 | 77.75 | 220 | 440 | 186 | 50.83 | 48.83 | −34.88 | 19.94 |
| OPM % | 10.0% | 15.0% | 22.0% | 16.0% | 7.0% | 20.0% | 22.0% | 9.0% | 2.5% | 2.4% | −2.0% | 1.1% |
| Other Income | 5.02 | 4.01 | 7.03 | 12.05 | 21.06 | 7.03 | 12.05 | 30.09 | 19.06 | 21.08 | 11.04 | 15.04 |
| Interest | 22.93 | 16.97 | 12.96 | 11.98 | 16.97 | 20.95 | 19.94 | 30.92 | 41.87 | 48.91 | 88.82 | 123 |
| Depreciation | 24.94 | 35.89 | 30.91 | 35.93 | 43.92 | 49.90 | 56.87 | 55.86 | 62.84 | 60.88 | 87.76 | 89.78 |
| Profit before tax | 55.04 | 109 | 253 | 169 | 38.05 | 157 | 375 | 129 | −35.02 | −41.02 | −202 | −176 |
| Tax % | 41.0% | 35.0% | 33.0% | 33.0% | 39.0% | 25.0% | 25.0% | 31.0% | 12.0% | 13.0% | −17.0% | — |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 1.01 | 0.00 | 0.00 | 0.00 | 0.00 | 2.01 | −8.01 | −7.99 |
| Net Profit | 32.09 | 71.14 | 170 | 114 | 23.04 | 118 | 281 | 90.23 | −39.06 | −46.13 | −168 | −152 |
| EPS (Rs) | 3.13 | 6.91 | 16.65 | 11.10 | 2.27 | 11.50 | 27.45 | 8.78 | −3.78 | −4.49 | −13.94 | −12.61 |
| Dividend payout % | 51.1% | 27.0% | 12.0% | 18.1% | 0.0% | 19.1% | 9.0% | 17.1% | −25.9% | 0.0% | 0.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 10.03 | 10.03 | 10.03 | 10.04 | 10.03 | 10.03 | 10.03 | 10.03 | 10.04 | 10.03 | 10.03 | 12.04 |
| Reserves | 183 | 208 | 388 | 563 | 658 | 628 | 794 | 1,076 | 1,183 | 1,136 | 1,146 | 1,554 |
| Borrowings | 142 | 91.23 | 62.13 | 50.14 | 103 | 198 | 183 | 165 | 515 | 1,254 | 1,790 | 2,180 |
| Other Liabilities | 211 | 211 | 326 | 202 | 370 | 365 | 357 | 609 | 651 | 923 | 866 | 1,003 |
| Total Liabilities | 547 | 520 | 786 | 825 | 1,141 | 1,200 | 1,343 | 1,861 | 2,359 | 3,323 | 3,811 | 4,748 |
| Fixed Assets | 244 | 257 | 318 | 311 | 384 | 552 | 514 | 598 | 673 | 714 | 1,254 | 1,255 |
| CWIP | 7.02 | 18.07 | 9.02 | 44.12 | 160 | 82.21 | 126 | 64.22 | 407 | 1,204 | 1,356 | 2,527 |
| Investments | 4.98 | 4.98 | 76.74 | 104 | 150 | 48.86 | 136 | 179 | 132 | 173 | 199 | 154 |
| Other Assets | 290 | 240 | 382 | 366 | 448 | 517 | 567 | 1,019 | 1,147 | 1,233 | 1,001 | 812 |
| Inventories | 98.12 | 69.12 | 152 | 126 | 191 | 147 | 132 | 242 | 319 | 251 | 248 | 186 |
| Trade receivables | 152 | 129 | 138 | 119 | 113 | 90.17 | 87.29 | 156 | 102 | 183 | 200 | 198 |
| Cash & equivalents | 11.01 | 13.99 | 35.98 | 46.98 | 58.01 | 214 | 309 | 549 | 545 | 599 | 357 | 262 |
| Total Assets | 547 | 520 | 786 | 825 | 1,141 | 1,200 | 1,343 | 1,861 | 2,359 | 3,323 | 3,811 | 4,748 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 154 | 126 | 108 | 80.85 | 234 | 140 | 221 | 402 | 53.93 | 237 | −65.90 | −131 |
| Cash from investing activity | −19.01 | −32.06 | −44.06 | −54.09 | −221 | −36.07 | −159 | −134 | −336 | −825 | −532 | −591 |
| Cash from financing activity | −143 | −93.37 | −52.19 | −16.07 | 16.05 | 46.16 | −38.16 | −70.25 | 207 | 646 | 376 | 606 |
| Net cash flow | −7.99 | 0.00 | 11.99 | 9.99 | 28.96 | 150 | 24.01 | 198 | −74.90 | 55.96 | −223 | −119 |
| Capex | 20.99 | 27.99 | 24.01 | 59.03 | 193 | 103 | 61.02 | 74.01 | 363 | 812 | 613 | 599 |
| Free cash flow | 132 | 98.26 | 85.21 | 22.08 | 41.11 | 38.10 | 161 | 330 | −309 | −576 | −678 | −732 |
| CFO / OP % | 422.0% | 147.0% | 91.0% | 57.0% | 137.0% | 190.0% | 118.0% | 108.0% | 66.0% | 480.0% | −90.0% | 384.0% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 52 | 50 | 49 | 33 | 33 | 30 | 29 | 29 | 17 | 32 | 35 | 41 |
| Inventory days | 42 | 38 | 82 | 59 | 84 | 69 | 74 | 74 | 76 | 55 | 57 | 50 |
| Days payable | 38 | 92 | 139 | 53 | 119 | 123 | 129 | 141 | 118 | 113 | 103 | 77 |
| Cash conversion cycle | 57 | −2 | −7 | 40 | −1 | −23 | −25 | −38 | −24 | −25 | −10 | 15 |
| Working capital days | −7 | −14 | −4 | 38 | 5 | −4 | −18 | −22 | −60 | −92 | −56 | −159 |
| ROCE % | 7.0% | 24.0% | 33.0% | 49.0% | 26.0% | 7.0% | 20.0% | 35.0% | 11.0% | 0.0% | 0.0% | −3.0% |
For the Jun 2026 quarter, Thirumalai Chemicals reported sales of ₹547 Cr, up 21.5% year on year and net profit of −₹44.12 Cr. The operating margin was 6.0%.
Thirumalai Chemicals' sales for the year to Mar 2026 were ₹1,737 Cr; over the last twelve months they were ₹1,833 Cr.
Net profit for the year to Mar 2026 was −₹168 Cr, and −₹152 Cr over the last twelve months. Earnings per share over the same trailing period were ₹−12.61.
Thirumalai Chemicals reported borrowings of ₹2,180 Cr at Mar 2026, against cash and equivalents of ₹262 Cr.
Cash from operations was −₹131 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹732 Cr.